Process paves a road to safe, ethical, and fast drug manufacturing Credit: Rensselaer Polytechnic Institute TROY, N.Y. — Envisioning an animal-free drug supply, scientists have —...
The MIT team Kano Therapeutics won the 2021 Sloan Healthcare Innovations Prize Thursday with its novel approach for producing single-stranded DNA (ssDNA). The technology could make...
SHANGHAI and HONG KONG, Feb. 28, 2021 /PRNewswire/ — Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing...
NEW YORK, Feb. 27, 2021 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in...
Credit: UM photo MISSOULA – University of Montana researchers and their partners have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs...
The Critical Path to Therapeutics for the Ataxias will optimize clinical trials for inherited ataxias Credit: C-Path TUCSON, Ariz., February 26, 2021 — Critical Path Institute...
WESTON, Fla., Feb. 26, 2021 /PRNewswire/ — ZyVersa Therapeutics, Inc. (ZyVersa), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal...
BEDMINSTER, New Jersey, 26 février 2021 /PRNewswire/ — Jubilant Therapeutics Inc., une société biopharmaceutique qui fait progresser les modulateurs à petites molécules pour répondre aux besoins...
STOCKHOLM, Feb. 26, 2021 /PRNewswire/ — XNK Therapeutics AB (“XNK”) today announced that it is entering into a joint Phase II clinical study to treat patients...
BEDMINSTER, New Jersey, 26. Februar 2021 /PRNewswire/ — Jubilant Therapeutics Inc. , ein biopharmazeutisches Unternehmen, das niedermolekulare Modulatoren entwickelt, um ungedeckten medizinischen Bedarf in der Onkologie...